Page last updated: 2024-12-07

1,3-dipropyl-8-(2-amino-4-chlorophenyl)xanthine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

1,3-dipropyl-8-(2-amino-4-chlorophenyl)xanthine, also known as **CPX**, is a synthetic compound that is a potent and selective **A2A adenosine receptor antagonist**.

Here's why it's important for research:

* **Understanding the Role of Adenosine Receptors:** CPX is a valuable tool for studying the role of A2A adenosine receptors in various physiological processes. These receptors are involved in a range of functions, including:
* **Neurotransmission:** Modulating neurotransmitter release and neuronal activity in the brain.
* **Cardiovascular function:** Regulating heart rate and blood pressure.
* **Inflammation:** Mediating inflammatory responses.
* **Sleep-wake cycles:** Contributing to sleep regulation.
* **Parkinson's disease:** Research suggests A2A antagonists may have therapeutic potential in Parkinson's disease.

* **Drug Discovery and Development:** CPX serves as a lead compound for the development of new drugs that target A2A receptors. Researchers use CPX to:
* **Identify potential drug candidates:** By studying its effects, they can learn which chemical modifications may enhance its activity or selectivity.
* **Develop new therapeutic strategies:** For example, A2A antagonists are being explored for the treatment of Parkinson's disease, Alzheimer's disease, and other neurological conditions.

* **Research into A2A Receptor Function:** CPX's high affinity and selectivity for A2A receptors make it a valuable tool for studying:
* **Signal transduction pathways:** Understanding how A2A receptors interact with other molecules within cells.
* **Pharmacological properties:** Investigating the mechanisms of action of A2A antagonists.
* **Effects on different tissues and organs:** Exploring the role of A2A receptors in diverse physiological systems.

**In summary, 1,3-dipropyl-8-(2-amino-4-chlorophenyl)xanthine (CPX) is a potent and selective A2A adenosine receptor antagonist that plays a crucial role in research by providing insights into the function of these receptors and their potential therapeutic applications.**

Cross-References

ID SourceID
PubMed CID92411
CHEMBL ID273671
SCHEMBL ID4650748
MeSH IDM0134401

Synonyms (23)

Synonym
85872-51-1
PDSP2_000977
PDSP2_001120
PDSP1_000993
PDSP1_001136
papcx
1,3-dipropyl-8-(2-amino-4-chlorophenyl)xanthine
pacpx
1h-purine-2,6-dione, 8-(2-amino-4-chlorophenyl)-3,7-dihydro-1,3-dipropyl
CHEMBL273671 ,
bdbm82013
nsc_92411
8-(2-amino-4-chloro-phenyl)-1,3-dipropyl-3,7-dihydro-purine-2,6-dione(pacpx)
cas_92411
8-(2-amino-4-chlorophenyl)-1,3-dipropylxanthine
unii-et7okc2mcy
et7okc2mcy ,
1h-purine-2,6-dione, 8-(2-amino-4-chlorophenyl)-3,7-dihydro-1,3-dipropyl-
1h-purine-2,6-dione, 8-(2-amino-4-chlorophenyl)-3,9-dihydro-1,3-dipropyl-
SENJBFBVCXOUFE-UHFFFAOYSA-N
SCHEMBL4650748
DTXSID90235182
Q27277352
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (5)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Adenosine receptor A1Rattus norvegicus (Norway rat)Ki0.00250.00011.20929.9700AID31856; AID32020; AID32177
Adenosine receptor A1Bos taurus (cattle)IC50 (µMol)548,240.00000.00001.09106.7400AID31836; AID31838
Adenosine receptor A1Bos taurus (cattle)Ki0.00000.00000.71316.0000AID31832
Adenosine receptor A2bRattus norvegicus (Norway rat)Ki1.00000.00061.353610.0000AID33568
Adenosine receptor A2aRattus norvegicus (Norway rat)Ki1.00000.00021.494010.0000AID33568
Adenosine receptor A2aCavia porcellus (domestic guinea pig)Ki1.00000.11002.63858.0000AID30621
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Adenosine receptor A2bRattus norvegicus (Norway rat)Ratio0.09200.00330.82929.6000AID33746
Adenosine receptor A2aRattus norvegicus (Norway rat)Ratio0.09200.00330.82309.6000AID33746
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (2)

Processvia Protein(s)Taxonomy
G protein-coupled adenosine receptor signaling pathwayAdenosine receptor A1Bos taurus (cattle)
response to purine-containing compoundAdenosine receptor A1Bos taurus (cattle)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (1)

Processvia Protein(s)Taxonomy
G protein-coupled adenosine receptor activityAdenosine receptor A2aRattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (1)

Processvia Protein(s)Taxonomy
Golgi membraneAdenosine receptor A2aRattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (21)

Assay IDTitleYearJournalArticle
AID31836Binding affinity against bovine brain adenosine A1 receptor by using N6-[3H]- cyclohexyladenosine1985Journal of medicinal chemistry, Aug, Volume: 28, Issue:8
Synthesis of xanthines as adenosine antagonists, a practical quantitative structure-activity relationship application.
AID23563Solubility in 0.1 N HCl1985Journal of medicinal chemistry, Aug, Volume: 28, Issue:8
Synthesis of xanthines as adenosine antagonists, a practical quantitative structure-activity relationship application.
AID54321log(1000/IC50 determined from bovine brain membrane) expressed as potency1985Journal of medicinal chemistry, Aug, Volume: 28, Issue:8
Synthesis of xanthines as adenosine antagonists, a practical quantitative structure-activity relationship application.
AID25618Equilibrium constant (pKa) was determined.1985Journal of medicinal chemistry, Aug, Volume: 28, Issue:8
Synthesis of xanthines as adenosine antagonists, a practical quantitative structure-activity relationship application.
AID30335Log IC50 value was determined against adenosine A1 receptor in rat brain membranes1985Journal of medicinal chemistry, Aug, Volume: 28, Issue:8
Synthesis of xanthines as adenosine antagonists, a practical quantitative structure-activity relationship application.
AID229822Ratio of antagonism at A2 versus A1 receptors (Ki values)1985Journal of medicinal chemistry, Apr, Volume: 28, Issue:4
1,3-Dialkyl-8-(p-sulfophenyl)xanthines: potent water-soluble antagonists for A1- and A2-adenosine receptors.
AID180145Inhibitory activity against rat brain membranes.1985Journal of medicinal chemistry, Aug, Volume: 28, Issue:8
Synthesis of xanthines as adenosine antagonists, a practical quantitative structure-activity relationship application.
AID23491Partition coefficient (logP)1985Journal of medicinal chemistry, Aug, Volume: 28, Issue:8
Synthesis of xanthines as adenosine antagonists, a practical quantitative structure-activity relationship application.
AID31832Inhibitory activity against adenosine A1 receptor in bovine brain membranes1983Journal of medicinal chemistry, Dec, Volume: 26, Issue:12
Neurotransmitter receptor binding and drug discovery.
AID33907Selectivity ratio was expressed as the ratio of binding affinity towards Adenosine A2 receptor to that of Adenosine A1 receptor in rat1986Journal of medicinal chemistry, Aug, Volume: 29, Issue:8
Analogues of 1,3-dipropyl-8-phenylxanthine: enhancement of selectivity at A1-adenosine receptors by aryl substituents.
AID23562Solubility in 0.1 M phosphate buffer at pH 7.41985Journal of medicinal chemistry, Aug, Volume: 28, Issue:8
Synthesis of xanthines as adenosine antagonists, a practical quantitative structure-activity relationship application.
AID33568Binding affinity against A2 adenosine receptors of the central nervous system1986Journal of medicinal chemistry, Aug, Volume: 29, Issue:8
Analogues of 1,3-dipropyl-8-phenylxanthine: enhancement of selectivity at A1-adenosine receptors by aryl substituents.
AID30621Antagonism of cyclic [3H]AMP accumulation in guinea pig cerebral cortical slices (elicited by 15 uM 2-chloroadenosine at adenosine A2 receptor)1985Journal of medicinal chemistry, Apr, Volume: 28, Issue:4
1,3-Dialkyl-8-(p-sulfophenyl)xanthines: potent water-soluble antagonists for A1- and A2-adenosine receptors.
AID32020Binding affinity against A1 adenosine receptors of the central nervous system1986Journal of medicinal chemistry, Aug, Volume: 29, Issue:8
Analogues of 1,3-dipropyl-8-phenylxanthine: enhancement of selectivity at A1-adenosine receptors by aryl substituents.
AID33746Binding affinity against adenosine A2 receptor using [3H]- NECA as radioligand1992Journal of medicinal chemistry, Feb-07, Volume: 35, Issue:3
Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential.
AID54298log(1000/IC50 determined from bovine brain membrane) expressed as potency1985Journal of medicinal chemistry, Aug, Volume: 28, Issue:8
Synthesis of xanthines as adenosine antagonists, a practical quantitative structure-activity relationship application.
AID33752Ratio of A2 to A1.1992Journal of medicinal chemistry, Feb-07, Volume: 35, Issue:3
Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential.
AID32497Inhibition of [3H]CHA binding to Adenosine A1 receptor in rat brain membranes1990Journal of medicinal chemistry, Jun, Volume: 33, Issue:6
A model for the antagonist binding site on the adenosine A1 receptor, based on steric, electrostatic, and hydrophobic properties.
AID31838Log IC50 value was determined against adenosine A1 receptor in bovine brain membranes1985Journal of medicinal chemistry, Aug, Volume: 28, Issue:8
Synthesis of xanthines as adenosine antagonists, a practical quantitative structure-activity relationship application.
AID32177Binding affinity against adenosine A1 receptor using [3H]-CHA or [3H]PIA as radioligand1992Journal of medicinal chemistry, Feb-07, Volume: 35, Issue:3
Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential.
AID31856Antagonism of binding of 1 nM [3H]cyclohexyladenosine to adenosine A1 receptors on rat cortical membranes1985Journal of medicinal chemistry, Apr, Volume: 28, Issue:4
1,3-Dialkyl-8-(p-sulfophenyl)xanthines: potent water-soluble antagonists for A1- and A2-adenosine receptors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (34)

TimeframeStudies, This Drug (%)All Drugs %
pre-199010 (29.41)18.7374
1990's20 (58.82)18.2507
2000's4 (11.76)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.76

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.76 (24.57)
Research Supply Index3.64 (2.92)
Research Growth Index4.39 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.76)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (5.41%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other35 (94.59%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]